![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RBM14 |
Gene summary for RBM14 |
![]() |
Gene information | Species | Human | Gene symbol | RBM14 | Gene ID | 10432 |
Gene name | RNA binding motif protein 14 | |
Gene Alias | COAA | |
Cytomap | 11q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | A0A0S2Z567 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10432 | RBM14 | HTA11_3410_2000001011 | Human | Colorectum | AD | 6.55e-04 | 1.28e-01 | 0.0155 |
10432 | RBM14 | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.24e-04 | 1.86e-01 | -0.0811 |
10432 | RBM14 | HTA11_78_2000001011 | Human | Colorectum | AD | 2.20e-05 | 1.60e-01 | -0.1088 |
10432 | RBM14 | HTA11_347_2000001011 | Human | Colorectum | AD | 7.02e-07 | 1.55e-01 | -0.1954 |
10432 | RBM14 | HTA11_411_2000001011 | Human | Colorectum | SER | 5.61e-03 | 2.55e-01 | -0.2602 |
10432 | RBM14 | HTA11_3361_2000001011 | Human | Colorectum | AD | 5.46e-03 | 1.69e-01 | -0.1207 |
10432 | RBM14 | HTA11_83_2000001011 | Human | Colorectum | SER | 2.04e-02 | 1.35e-01 | -0.1526 |
10432 | RBM14 | HTA11_696_2000001011 | Human | Colorectum | AD | 4.46e-07 | 1.63e-01 | -0.1464 |
10432 | RBM14 | HTA11_866_2000001011 | Human | Colorectum | AD | 1.71e-02 | 9.74e-02 | -0.1001 |
10432 | RBM14 | HTA11_1391_2000001011 | Human | Colorectum | AD | 3.65e-10 | 2.44e-01 | -0.059 |
10432 | RBM14 | HTA11_5216_2000001011 | Human | Colorectum | SER | 3.40e-02 | 1.93e-01 | -0.1462 |
10432 | RBM14 | HTA11_866_3004761011 | Human | Colorectum | AD | 1.36e-07 | 1.83e-01 | 0.096 |
10432 | RBM14 | HTA11_10623_2000001011 | Human | Colorectum | AD | 8.98e-03 | 1.87e-01 | -0.0177 |
10432 | RBM14 | HTA11_6801_2000001011 | Human | Colorectum | SER | 2.21e-02 | 3.87e-01 | 0.0171 |
10432 | RBM14 | HTA11_7696_3000711011 | Human | Colorectum | AD | 9.32e-10 | 2.13e-01 | 0.0674 |
10432 | RBM14 | HTA11_7469_2000001011 | Human | Colorectum | AD | 3.81e-02 | 2.45e-01 | -0.0124 |
10432 | RBM14 | HTA11_6818_2000001021 | Human | Colorectum | AD | 2.64e-03 | 1.45e-01 | 0.0588 |
10432 | RBM14 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 2.05e-06 | 1.74e-01 | 0.294 |
10432 | RBM14 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 5.36e-07 | 5.36e-01 | 0.3487 |
10432 | RBM14 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 7.49e-10 | 3.40e-01 | 0.281 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0008380 | Colorectum | AD | RNA splicing | 169/3918 | 434/18723 | 3.59e-18 | 2.04e-15 | 169 |
GO:0000377 | Colorectum | AD | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
GO:0000398 | Colorectum | AD | mRNA splicing, via spliceosome | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
GO:0000375 | Colorectum | AD | RNA splicing, via transesterification reactions | 131/3918 | 324/18723 | 7.11e-16 | 2.22e-13 | 131 |
GO:0010639 | Colorectum | AD | negative regulation of organelle organization | 114/3918 | 348/18723 | 1.41e-07 | 6.49e-06 | 114 |
GO:0051494 | Colorectum | AD | negative regulation of cytoskeleton organization | 58/3918 | 163/18723 | 1.04e-05 | 2.40e-04 | 58 |
GO:0007178 | Colorectum | AD | transmembrane receptor protein serine/threonine kinase signaling pathway | 99/3918 | 355/18723 | 9.92e-04 | 9.28e-03 | 99 |
GO:0060395 | Colorectum | AD | SMAD protein signal transduction | 28/3918 | 82/18723 | 3.73e-03 | 2.63e-02 | 28 |
GO:0046605 | Colorectum | AD | regulation of centrosome cycle | 18/3918 | 49/18723 | 7.93e-03 | 4.73e-02 | 18 |
GO:00083801 | Colorectum | SER | RNA splicing | 123/2897 | 434/18723 | 3.84e-12 | 8.41e-10 | 123 |
GO:00003751 | Colorectum | SER | RNA splicing, via transesterification reactions | 90/2897 | 324/18723 | 8.68e-09 | 7.50e-07 | 90 |
GO:00003771 | Colorectum | SER | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 89/2897 | 320/18723 | 9.82e-09 | 8.14e-07 | 89 |
GO:00003981 | Colorectum | SER | mRNA splicing, via spliceosome | 89/2897 | 320/18723 | 9.82e-09 | 8.14e-07 | 89 |
GO:00106391 | Colorectum | SER | negative regulation of organelle organization | 90/2897 | 348/18723 | 3.14e-07 | 1.69e-05 | 90 |
GO:00514941 | Colorectum | SER | negative regulation of cytoskeleton organization | 48/2897 | 163/18723 | 4.34e-06 | 1.63e-04 | 48 |
GO:00466051 | Colorectum | SER | regulation of centrosome cycle | 17/2897 | 49/18723 | 7.17e-04 | 9.44e-03 | 17 |
GO:0010824 | Colorectum | SER | regulation of centrosome duplication | 15/2897 | 45/18723 | 2.29e-03 | 2.19e-02 | 15 |
GO:00083802 | Colorectum | MSS | RNA splicing | 159/3467 | 434/18723 | 1.75e-19 | 1.22e-16 | 159 |
GO:00003772 | Colorectum | MSS | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 121/3467 | 320/18723 | 2.52e-16 | 8.27e-14 | 121 |
GO:00003982 | Colorectum | MSS | mRNA splicing, via spliceosome | 121/3467 | 320/18723 | 2.52e-16 | 8.27e-14 | 121 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
RBM14 | SNV | Missense_Mutation | novel | c.1739G>A | p.Arg580His | p.R580H | Q96PK6 | protein_coding | deleterious(0) | benign(0) | TCGA-XK-AAIW-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 9 | Unknown | Unknown | PD |
RBM14 | SNV | Missense_Mutation | c.1721N>T | p.Pro574Leu | p.P574L | Q96PK6 | protein_coding | tolerated(0.05) | benign(0.003) | TCGA-BR-4292-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | rs752831172 | c.1463N>T | p.Ala488Val | p.A488V | Q96PK6 | protein_coding | deleterious(0.01) | probably_damaging(0.935) | TCGA-BR-4361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
RBM14 | SNV | Missense_Mutation | c.986N>G | p.Asn329Ser | p.N329S | Q96PK6 | protein_coding | tolerated(1) | benign(0.048) | TCGA-BR-4368-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | c.17N>A | p.Gly6Asp | p.G6D | Q96PK6 | protein_coding | deleterious(0) | possibly_damaging(0.573) | TCGA-BR-A4IY-01 | Stomach | stomach adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
RBM14 | SNV | Missense_Mutation | c.752C>T | p.Ala251Val | p.A251V | Q96PK6 | protein_coding | deleterious(0.01) | possibly_damaging(0.546) | TCGA-CG-4306-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | c.1094N>G | p.Tyr365Cys | p.Y365C | Q96PK6 | protein_coding | deleterious(0.01) | probably_damaging(0.984) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | c.1660N>T | p.Pro554Ser | p.P554S | Q96PK6 | protein_coding | deleterious(0.04) | benign(0.006) | TCGA-CG-5721-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | c.17N>C | p.Gly6Ala | p.G6A | Q96PK6 | protein_coding | deleterious(0) | possibly_damaging(0.49) | TCGA-D7-A6EX-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
RBM14 | SNV | Missense_Mutation | rs747929881 | c.640C>T | p.Arg214Cys | p.R214C | Q96PK6 | protein_coding | deleterious(0) | possibly_damaging(0.551) | TCGA-F1-6177-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |